Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NextPlat CorpNXPL · Entity 7521 | CFO | October 01, 2024 | October 04, 2024 |
| Progressive Care Inc.RXMD · Entity 108817 | Chief Financial Officer | November 14, 2022 | November 16, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NextPlat Corp
Report date October 01, 2024 · Filed October 04, 2024 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.90 · Expires 2031-11-22 | Direct | 37,163 |
Reported balance
Holding disclosure · report date 2024-10-01 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 37,163 F1: In connection with the Merger of Progressive Care Inc. into the Issuer, the Reporting Person received stock options to acquire 37,163 shares of the Issuer's common stock in exchange for stock options to acquire 25,000 shares of Progressive Care Inc. The options are fully vested. F2: On October 3, 2024, the Reporting Person filed a Form 4 which inadvertently reported beneficial ownership of 92,163 stock options. In fact, as reported in this amendment, the Reporting Person directly owned stock options to acquire 37,163 shares of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: In connection with the Merger of Progressive Care Inc. into the Issuer, the Reporting Person received stock options to acquire 37,163 shares of the Issuer's common stock in exchange for stock options to acquire 25,000 shares of Progressive Care Inc. The options are fully vested.
F2: On October 3, 2024, the Reporting Person filed a Form 4 which inadvertently reported beneficial ownership of 92,163 stock options. In fact, as reported in this amendment, the Reporting Person directly owned stock options to acquire 37,163 shares of the Issuer's common stock.
Progressive Care Inc.
Report date November 14, 2022 · Filed November 16, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security | Direct | 5,000,000 |
Reported balance
After 2022-11-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-11-14 · Grant · Acquired 5,000,000 · Balance 5,000,000 F1: The options vested immediately but have not been exercised pursuant to the Stock Option Award Agreement. F2: The price per share of the Shares subject to the Option shall not be less than 100% of the Fair Market Value of a Share on the Date of Grant. Notwithstanding the foregoing, if this Option is designated as an Incentive Stock Option and the Reporting Person is a Ten Percent Holder as of the Date of Grant, the exercise price per share of the Shares subject to the Option shall not be less than 110% of the Fair Market Value of a Share on the Date of Grant. F3: The Option shall commence on Grant Date and terminate on the date of first to occur of: (1) If Option is designated as an Incentive Stock Option and Reporting Person, at time Option was granted, was a 10% Holder, the expiration of (5) years from Date of Grant; (2) 10th anniversary of Date of Grant; (3) (1) year following Reporting Person's termination of Continuous Service Status with Issuer and its Affiliates as a result of termination of service of Reporting Person by Issuer or any of its Affiliates on account of death or Disability; (4) (30) days following Reporting Person's termination of service of a Participant with Issuer and its Affiliates as a result of termination of service of a Participant by Reporting Person other than for Cause; and (5) Close of business on last business day immediately prior to date of Reporting Person's termination of service by Issuer for Cause or for any reason other than as set forth above. F4: This number does not represent the 1,000,000 shares of the Company's common stock, or non-derivative securities, held by Cecile Munnik as of the date of this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vested immediately but have not been exercised pursuant to the Stock Option Award Agreement.
F2: The price per share of the Shares subject to the Option shall not be less than 100% of the Fair Market Value of a Share on the Date of Grant. Notwithstanding the foregoing, if this Option is designated as an Incentive Stock Option and the Reporting Person is a Ten Percent Holder as of the Date of Grant, the exercise price per share of the Shares subject to the Option shall not be less than 110% of the Fair Market Value of a Share on the Date of Grant.
F3: The Option shall commence on Grant Date and terminate on the date of first to occur of: (1) If Option is designated as an Incentive Stock Option and Reporting Person, at time Option was granted, was a 10% Holder, the expiration of (5) years from Date of Grant; (2) 10th anniversary of Date of Grant; (3) (1) year following Reporting Person's termination of Continuous Service Status with Issuer and its Affiliates as a result of termination of service of Reporting Person by Issuer or any of its Affiliates on account of death or Disability; (4) (30) days following Reporting Person's termination of service of a Participant with Issuer and its Affiliates as a result of termination of service of a Participant by Reporting Person other than for Cause; and (5) Close of business on last business day immediately prior to date of Reporting Person's termination of service by Issuer for Cause or for any reason other than as set forth above.
F4: This number does not represent the 1,000,000 shares of the Company's common stock, or non-derivative securities, held by Cecile Munnik as of the date of this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2024 Filed Oct 3, 2024 21:06 UTC | NextPlat Corp NXPL · Entity 7521 | GrantEmployee Stock Option (right to buy) · Derivative | 37,163 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0001437749-24-030636 · rdgdoc.xml · derivative · entry 2 Munnik Cecile · CIK 0001901022 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,163 Underlying: Common Stock · 37,163 shares Expires 2031-11-22 F2 · derivative.exercise_date: In connection with the Merger, the Report Person received stock options to acquire 37,163 shares of the Issuer's common stock in exchange for stock options to acquire 25,000 shares of Progressive Care Inc. The options are fully vested. F3 · balance_after: Represents 75,496 stock options that are fully vested. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 21:06 UTC | NextPlat Corp NXPL · Entity 7521 | GrantCommon Stock | 7,433 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-030636 · rdgdoc.xml · nonDerivative · entry 1 Munnik Cecile · CIK 0001901022 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,433 F1 · price: On October 1, 2024, the Reporting Person received 7,433 shares of the Issuer's common stock in exchange for 5,000 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq. Read SEC document |
| April 07, 2023 Filed Jun 9, 2023 19:49 UTC | NextPlat Corp NXPL · Entity 7521 | GrantStock Options · Derivative | 5,000 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001493152-23-020710 · ownership.xml · derivative · entry 2 Munnik Cecile · CIK 0001901022 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 5,000 shares Expires 2028-04-07 F3 · price: The options were granted pursuant to the Issuer's 2021 Incentive Award Plan. F2 · derivative.exercise_date: On April 7, 2023, Ms. Munnik entered into a Stock Option Agreement with the Issuer pursuant to which Ms. Munnik was granted an option to purchase 5,000 shares of Issuer's common stock, of which one third of the shares of common stock vest immediately on the Grant Date, with options to purchase an additional third of the shares of common stock vesting on the one-year anniversary of the Grant Date, and options to purchase the remaining third of the shares of common stock vesting on the second-year anniversary of the Grant Date. Read SEC document |
| April 07, 2023 Filed Jun 9, 2023 19:49 UTC | NextPlat Corp NXPL · Entity 7521 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-020710 · ownership.xml · nonDerivative · entry 1 Munnik Cecile · CIK 0001901022 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 F1 · shares: On April 7, 2023, Ms. Munnik entered into a Restricted Stock Award Agreement with the Issuer, pursuant to which Ms. Munnik was awarded 5,000 shares of Issuer's common stock. The restricted stock vests immediately upon issuance. F3 · price: The options were granted pursuant to the Issuer's 2021 Incentive Award Plan. Read SEC document |
| November 14, 2022 Filed Nov 16, 2022 16:41 UTC | Progressive Care Inc. RXMD · Entity 108817 | GrantStock Option · Derivative | 5,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-22-032640 · ownership.xml · derivative · entry 1 Munnik Cecile · CIK 0001901022 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000,000 Underlying: Common Stock · 5,000,000 shares Expires not disclosed F1 · security: The options vested immediately but have not been exercised pursuant to the Stock Option Award Agreement. F2 · derivative.exercise_price: The price per share of the Shares subject to the Option shall not be less than 100% of the Fair Market Value of a Share on the Date of Grant. Notwithstanding the foregoing, if this Option is designated as an Incentive Stock Option and the Reporting Person is a Ten Percent Holder as of the Date of Grant, the exercise price per share of the Shares subject to the Option shall not be less than 110% of the Fair Market Value of a Share on the Date of Grant. F1 · price: The options vested immediately but have not been exercised pursuant to the Stock Option Award Agreement. F3 · derivative.exercise_date: The Option shall commence on Grant Date and terminate on the date of first to occur of: (1) If Option is designated as an Incentive Stock Option and Reporting Person, at time Option was granted, was a 10% Holder, the expiration of (5) years from Date of Grant; (2) 10th anniversary of Date of Grant; (3) (1) year following Reporting Person's termination of Continuous Service Status with Issuer and its Affiliates as a result of termination of service of Reporting Person by Issuer or any of its Affiliates on account of death or Disability; (4) (30) days following Reporting Person's termination of service of a Participant with Issuer and its Affiliates as a result of termination of service of a Participant by Reporting Person other than for Cause; and (5) Close of business on last business day immediately prior to date of Reporting Person's termination of service by Issuer for Cause or for any reason other than as set forth above. F3 · derivative.expiration_date: The Option shall commence on Grant Date and terminate on the date of first to occur of: (1) If Option is designated as an Incentive Stock Option and Reporting Person, at time Option was granted, was a 10% Holder, the expiration of (5) years from Date of Grant; (2) 10th anniversary of Date of Grant; (3) (1) year following Reporting Person's termination of Continuous Service Status with Issuer and its Affiliates as a result of termination of service of Reporting Person by Issuer or any of its Affiliates on account of death or Disability; (4) (30) days following Reporting Person's termination of service of a Participant with Issuer and its Affiliates as a result of termination of service of a Participant by Reporting Person other than for Cause; and (5) Close of business on last business day immediately prior to date of Reporting Person's termination of service by Issuer for Cause or for any reason other than as set forth above. F4 · balance_after: This number does not represent the 1,000,000 shares of the Company's common stock, or non-derivative securities, held by Cecile Munnik as of the date of this Form 4. Read SEC document |
| November 14, 2022 Filed Dec 5, 2022 13:02 UTC | NextPlat Corp NXPL · Entity 7521 | GrantStock Options · Derivative | 50,000 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001493152-22-034419 · ownership.xml · derivative · entry 1 Munnik Cecile · CIK 0001901022 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-11-14 F2 · price: The options were granted as an inducement for Ms. Munnik to enter into her employment agreement with the Issuer. F1 · derivative.underlying_shares: On December 5, 2022, Ms. Munnik entered into a Stock Option Agreement with the Issuer with an effective date of November 14, 2022 pursuant to which Ms. Munnik was granted an option to purchase 50,000 shares of Issuer's common stock, of which options to purchase 25,000 shares of common stock vest immediately on the Grant Date, with options to purchase an additional 10,000 shares of common stock vesting on the one-year anniversary of the Grant Date, and options to purchase the remaining 15,000 shares of common stock vesting on the second-year anniversary of the Grant Date. Read SEC document |
| December 13, 2021 Filed Dec 23, 2021 13:54 UTC | Progressive Care Inc. RXMD · Entity 108817 | PurchaseCommon Stock | 17,024 | $0.03 | $544.77 |
DisclosureSEC source: 0001213900-21-067267 · ownership.xml · nonDerivative · entry 2 Munnik Cecile · CIK 0001901022 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 532,000 Read SEC document |
| December 13, 2021 Filed Jan 6, 2022 10:11 UTC Amendment | Progressive Care Inc. RXMD · Entity 108817 | PurchaseCommon Stock | 532,000 | $0.03 | $17,024.00 |
DisclosureSEC source: 0001213900-22-000881 · ownership.xml · nonDerivative · entry 2 Munnik Cecile · CIK 0001901022 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 F1 · shares: The original Form 4 was filed on December 23, 2021. This amendment is being filed to correct an administrative error in reporting the amount of securities acquired and the amount of securities beneficially owned following reported transactions in Columns 4 and 5, respectively, in Table I. F1 · balance_after: The original Form 4 was filed on December 23, 2021. This amendment is being filed to correct an administrative error in reporting the amount of securities acquired and the amount of securities beneficially owned following reported transactions in Columns 4 and 5, respectively, in Table I. Read SEC document |
| December 10, 2021 Filed Dec 23, 2021 13:54 UTC | Progressive Care Inc. RXMD · Entity 108817 | PurchaseCommon Stock | 14,946 | $0.03 | $478.27 |
DisclosureSEC source: 0001213900-21-067267 · ownership.xml · nonDerivative · entry 1 Munnik Cecile · CIK 0001901022 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,000 Read SEC document |
| December 10, 2021 Filed Jan 6, 2022 10:11 UTC Amendment | Progressive Care Inc. RXMD · Entity 108817 | PurchaseCommon Stock | 468,000 | $0.03 | $14,976.00 |
DisclosureSEC source: 0001213900-22-000881 · ownership.xml · nonDerivative · entry 1 Munnik Cecile · CIK 0001901022 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,000 F1 · shares: The original Form 4 was filed on December 23, 2021. This amendment is being filed to correct an administrative error in reporting the amount of securities acquired and the amount of securities beneficially owned following reported transactions in Columns 4 and 5, respectively, in Table I. F1 · balance_after: The original Form 4 was filed on December 23, 2021. This amendment is being filed to correct an administrative error in reporting the amount of securities acquired and the amount of securities beneficially owned following reported transactions in Columns 4 and 5, respectively, in Table I. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.